+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rapid Pathogen Detection Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Rapid Test Kits, Consumables & Reagents), Technology (Immunoassays, NAAT), Application, End-use and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 130 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214610
REQUEST CUSTOMIZATION
Description Jump to:
The global rapid pathogen detection diagnostics market size was estimated at USD 21.05 billion in 2024 and is projected to reach USD 30.90 billion by 2033, growing at a CAGR of 4.48% from 2025 to 2033. The growth is driven by growing demand for point-of-care testing, rising awareness and screening programs, as well as increasing product launches and approvals.

The increasing emphasis on early detection and timely intervention in infectious diseases has led healthcare systems to prioritize rapid diagnostic solutions that offer speed, accuracy, and portability. These technologies are becoming essential tools in clinical decision-making, outbreak management, and infection control across hospitals, clinics, and community healthcare settings. For instance, in July 2025, Becton, Dickinson, and Company received U.S. FDA 510(k) clearance for the BD Veritor System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic people in approximately 15 minutes at doctors' offices, urgent care centers, retail clinics, and other convenient points of care.

Moreover, the increasing number of government programs, public health initiatives, and funding efforts aimed at controlling and preventing bacterial diseases are boosting the growth of the rapid pathogen detection diagnostics market. National and international agencies are investing in early detection technologies and point-of-care diagnostic tools to strengthen outbreak preparedness. For instance, in 2024, the WHO announced that, as part of a landmark global health initiative, more than 1.2 million cholera rapid diagnostic test kits were deployed across 14 countries, marking the largest coordinated effort of its kind. This rollout marked the first official implementation of its diagnostic support framework, real-time surveillance, significantly enhancing early detection, and the strategic execution of cholera vaccination campaigns. Thus, the global procurement and distribution program was the result of such collaborative effort among Gavi, WHO, UNICEF, FIND, and other partners committed to strengthening global health security.

Furthermore, the decreasing prices of molecular rapid diagnostic tests for infectious diseases, particularly tuberculosis, are presenting lucrative opportunities for the market. Affordable and accessible diagnostics enable wider adoption in hospitals, clinics, and resource-limited settings, improving early detection and treatment outcomes. For instance, in September 2023, Danaher’s (U.S.) subsidiary, Cepheid, announced a reduction in the price of its primary GeneXpert tuberculosis (TB) diagnostic test, lowering it from USD 9.98 to USD 7.97 in response to pressure from TB advocacy groups. The reduction in diagnostic costs is also facilitating the growth of point-of-care testing in decentralized and rural healthcare settings where laboratory infrastructure remains limited. Affordable diagnostics, coupled with continuous technological advancements like automated sample processing and faster turnaround times, are enabling healthcare providers to provide accurate and timely results, which will ultimately strengthen efforts to monitor and control disease. As a result, the downward trend in molecular test prices is helping to lower the morbidity and mortality of infectious diseases worldwide, in addition to increasing market penetration.

Global Rapid Pathogen Detection Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global rapid pathogen detection diagnostics market report based on product, technology, application, end-use, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Instruments
  • Rapid Test Kits
  • Consumables & Reagents
  • Software & Connectivity

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Immunoassays
  • Nucleic Acid Amplification Tests (NAAT)
  • Next-Generation Sequencing & Rapid Genotyping
  • Biosensors, Microfluidics & Lab-on-Chip
  • Others (CRISPR)

Application Outlook (Revenue, USD Million, 2021-2033)

  • Clinical Diagnostics
  • Public-health Surveillance & Outbreak Response
  • Food Safety & Environmental Monitoring
  • Others

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinical Labs
  • Point-of-Care
  • Public-health Labs
  • Food Testing Labs
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Rapid Pathogen Detection Diagnostics Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product
1.1.1.2. Technology Segment
1.1.1.3. Application Segment
1.1.1.4. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Rapid Pathogen Detection Diagnostics Market: Executive Summary
2.1. Market Snapshot
2.2. Product
2.3. Technology Snapshot
2.4. Application Snapshot
2.5. End Use Snapshot
2.6. Competitive Landscape Snapshot
Chapter 3. Rapid Pathogen Detection Diagnostics Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Growing demand for point-of-care testing
3.4.2. Rising awareness and screening programs
3.4.3. increasing product launches and approvals
3.5. Market Restraint Analysis
3.5.1. High cost of advanced technologies
3.5.2. Regulatory hurdles and lengthy approval processes
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis
Chapter 4. Rapid Pathogen Detection Diagnostics Market: Product Estimates & Trend Analysis
4.1. Rapid Pathogen Detection Diagnostics Market: Product Movement Analysis
4.2. Instruments
4.2.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.3. Rapid Test Kits
4.3.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Consumables & Reagents
4.4.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Software & Connectivity
4.5.1. Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Rapid Pathogen Detection Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Rapid Pathogen Detection Diagnostics Market: Technology Movement Analysis
5.2. Immunoassays
5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.3. Nucleic Acid Amplification Tests (NAAT)
5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Next-Generation Sequencing & Rapid Genotyping
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Biosensors, Microfluidics & Lab-on-Chip
5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others (CRISPER)
5.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Rapid Pathogen Detection Diagnostics Market: Application Estimates & Trend Analysis
6.1. Rapid Pathogen Detection Diagnostics Market: End Use Movement Analysis
6.2. Clinical Diagnostics
6.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.2. Respiratory Infections
6.2.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.3. Sexually Transmitted Infections (STIs)
6.2.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.4. Bloodborne & Hepatic Infections
6.2.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.5. Gastrointestinal Pathogens
6.2.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.6. Tropical & Vector-Borne Diseases
6.2.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.2.7. Others
6.2.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.3. Public-health Surveillance & Outbreak Response
6.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Food Safety & Environmental Monitoring
6.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Others
6.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Rapid Pathogen Detection Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Rapid Pathogen Detection Diagnostics Market: End Use Movement Analysis
7.2. Hospitals & Clinical Labs
7.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.3. Point-of-Care
7.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.4. Public-health Labs
7.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Food Testing Labs
7.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Others
7.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Rapid Pathogen Detection Diagnostics Market: Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Rapid Pathogen Detection Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Reimbursement Scenario
8.2.2.5. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Reimbursement Scenario
8.2.3.5. Competitive Scenario
8.2.4. Mexico
8.2.4.1. Mexico Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.2.4.2. Key Country Dynamics
8.2.4.3. Regulatory Framework
8.2.4.4. Reimbursement Scenario
8.2.4.5. Competitive Scenario
8.3. Europe
8.3.1. Europe Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.2. UK
8.3.2.1. UK Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Reimbursement Scenario
8.3.2.5. Competitive Scenario
8.3.3. Germany
8.3.3.1. Germany Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Reimbursement Scenario
8.3.3.5. Competitive Scenario
8.3.4. Spain
8.3.4.1. Spain Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Reimbursement Scenario
8.3.4.5. Competitive Scenario
8.3.5. France
8.3.5.1. France Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Reimbursement Scenario
8.3.5.5. Competitive Scenario
8.3.6. Italy
8.3.6.1. Italy Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Reimbursement Scenario
8.3.6.5. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Reimbursement Scenario
8.3.7.5. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Reimbursement Scenario
8.3.8.5. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Reimbursement Scenario
8.3.9.5. Competitive Scenario
8.4. Asia-Pacific
8.4.1. Asia-Pacific Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Scenario
8.4.2.5. Competitive Scenario
8.4.3. China
8.4.3.1. China Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Scenario
8.4.3.5. Competitive Scenario
8.4.4. India
8.4.4.1. India Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Scenario
8.4.4.5. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Reimbursement Scenario
8.4.5.5. Competitive Scenario
8.4.6. Thailand
8.4.6.1. Thailand Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Reimbursement Scenario
8.4.6.5. Competitive Scenario
8.4.7. Australia
8.4.7.1. Australia Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Reimbursement Scenario
8.4.7.5. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Scenario
8.5.2.5. Competitive Scenario
8.5.3. Argentina
8.5.3.1. Argentina Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Scenario
8.5.3.5. Competitive Scenario
8.6. MEA
8.6.1. MEA Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Scenario
8.6.2.5. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Scenario
8.6.3.5. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Scenario
8.6.4.5. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Rapid Pathogen Detection Diagnostics Market, 2021-2033 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Scenario
8.6.5.5. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. New Product Launch
9.2.2. Partnerships
9.2.3. Acquisition
9.2.4. Collaboration
9.2.5. Funding
9.3. Key Company Market Share Analysis, 2024
9.4. Company Heat Map Analysis
9.5. Company Profiles
9.5.1. F. Hoffmann-La Roche Ltd
9.5.1.1. Company Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Thermo Fisher Scientific Inc.
9.5.2.1. Company Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. BIOMÉRIEUX
9.5.3.1. Company Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Danaher Corporation
9.5.4.1. Company Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. DiaSorin
9.5.5.1. Company Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Becton, Dickinson and Company (BD)
9.5.6.1. Company Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. QIAGEN
9.5.7.1. Company Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Siemens Healthineers AG
9.5.8.1. Company Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. PerkinElmer
9.5.9.1. Company Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Illumina, Inc.
9.5.10.1. Company Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
9.5.11. Agilent Technologies, Inc.
9.5.11.1. Company Overview
9.5.11.2. Financial Performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic Initiatives
9.5.12. Bio-Rad Laboratories, Inc.
9.5.12.1. Company Overview
9.5.12.2. Financial Performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic Initiatives
9.5.13. Eurofins Scientific
9.5.13.1. Company Overview
9.5.13.2. Financial Performance
9.5.13.3. Product Benchmarking
9.5.13.4. Strategic Initiatives
9.5.14. Charles River Laboratories
9.5.14.1. Company Overview
9.5.14.2. Financial Performance
9.5.14.3. Product Benchmarking
9.5.14.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviation
Table 3 Global Rapid Pathogen Detection Diagnostics Market, By Region, 2021-2033 (USD Million)
Table 4 Global Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 5 Global Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 6 Global Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 7 Global Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 8 North America Rapid Pathogen Detection Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 9 North America Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 10 North America Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 11 North America Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 12 North America Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 13 U.S. Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 14 U.S. Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 15 U.S. Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 16 U.S. Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 17 Canada Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 18 Canada Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 19 Canada Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 20 Canada Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 21 Mexico Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 22 Mexico Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 23 Mexico Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 24 Mexico Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 25 Europe Rapid Pathogen Detection Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 26 Europe Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 27 Europe Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 28 Europe Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 29 Europe Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 30 UK Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 31 UK Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 32 UK Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 33 UK Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 34 Germany Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 35 Germany Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 36 Germany Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 37 Germany Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 38 France Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 39 France Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 40 France Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 41 France Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 42 Italy Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 43 Italy Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 44 Italy Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 45 Italy Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 46 Spain Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 47 Spain Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 48 Spain Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 49 Spain Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 50 Sweden Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 51 Sweden Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 52 Sweden Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 53 Sweden Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 54 Norway Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 55 Norway Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 56 Norway Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 57 Norway Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 58 Denmark Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 59 Denmark Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 60 Denmark Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 61 Denmark Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 62 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 63 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 64 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 65 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 66 Asia-Pacific Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 67 Japan Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 68 Japan Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 69 Japan Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 70 Japan Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 71 China Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 72 China Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 73 China Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 74 China Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 75 India Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 76 India Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 77 India Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 78 India Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 79 Australia Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 80 Australia Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 81 Australia Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 82 Australia Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 83 Thailand Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 84 Thailand Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 85 Thailand Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 86 Thailand Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 87 South Korea Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 88 South Korea Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 89 South Korea Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 90 South Korea Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 91 Latin America Rapid Pathogen Detection Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 92 Latin America Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 93 Latin America Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 94 Latin America Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 95 Latin America Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 96 Brazil Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 97 Brazil Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 98 Brazil Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 99 Brazil Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 100 Argentina Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 101 Argentina Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 102 Argentina Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 103 Argentina Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 104 MEA Rapid Pathogen Detection Diagnostics Market, By Country, 2021-2033 (USD Million)
Table 105 MEA Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 106 MEA Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 107 MEA Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 108 MEA Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 109 South Africa Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 110 South Africa Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 111 South Africa Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 112 South Africa Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 113 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 114 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 115 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 116 Saudi Arabia Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 117 UAE Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 118 UAE Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 119 UAE Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 120 UAE Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
Table 121 Kuwait Rapid Pathogen Detection Diagnostics Market, By Product, 2021-2033 (USD Million)
Table 122 Kuwait Rapid Pathogen Detection Diagnostics Market, By Technology, 2021-2033 (USD Million)
Table 123 Kuwait Rapid Pathogen Detection Diagnostics Market, By Application, 2021-2033 (USD Million)
Table 124 Kuwait Rapid Pathogen Detection Diagnostics Market, By End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Market summary
Figure 4 Market segmentation & scope
Figure 5 Market size and growth prospects
Figure 6 Global rapid pathogen detection diagnostics market- Key market driver analysis
Figure 7 Global rapid pathogen detection diagnostics market - Key market restraint analysis
Figure 8 Penetration & growth prospect mapping
Figure 9 Global rapid pathogen detection diagnostics market - Porter’s analysis
Figure 10 Global rapid pathogen detection diagnostics market - PESTEL analysis
Figure 11 Global rapid pathogen detection diagnostics market: Product outlook key takeaways
Figure 12 Global rapid pathogen detection diagnostics market: Product movement analysis
Figure 13 Instruments market estimates, 2021-2033 (USD Million)
Figure 14 Rapid test kits market estimates, 2021-2033 (USD Million)
Figure 15 consumables & reagents market estimates, 2021-2033 (USD Million)
Figure 16 software & connectivity market estimates, 2021-2033 (USD Million)
Figure 17 Global rapid pathogen detection diagnostics market: Technology outlook key takeaways
Figure 18 Global rapid pathogen detection diagnostics market: Technology movement analysis
Figure 19 Immunoassays market estimates, 2021-2033 (USD Million)
Figure 20 Nucleic acid amplification tests (NAAT) market estimates, 2021-2033 (USD Million)
Figure 21 Next-Generation sequencing & rapid genotyping market estimates, 2021-2033 (USD Million)
Figure 22 Biosensors, microfluidics & lab-on-chip market estimates, 2021-2033 (USD Million)
Figure 23 Others (CRISPR) market estimates, 2021-2033 (USD Million)
Figure 24 Global rapid pathogen detection diagnostics market: Application outlook key takeaways
Figure 25 Global rapid pathogen detection diagnostics market: Application movement analysis
Figure 26 Clinical diagnostics market estimates, 2021-2033 (USD Million)
Figure 27 Respiratory infections market estimates, 2021-2033 (USD Million)
Figure 28 Sexually transmitted infections (STIS) market estimates, 2021-2033 (USD Million)
Figure 29 Bloodborne & hepatic infections market estimates, 2021-2033 (USD Million)
Figure 30 Gastrointestinal pathogens market estimates, 2021-2033 (USD Million)
Figure 31 Tropical & vector-borne diseases market estimates, 2021-2033 (USD Million)
Figure 32 Others market estimates, 2021-2033 (USD Million)
Figure 33 Public-health surveillance & outbreak response market estimates, 2021-2033 (USD Million)
Figure 34 Food safety & environmental monitoring market estimates, 2021-2033 (USD Million)
Figure 35 Others market estimates, 2021-2033 (USD Million)
Figure 36 Global rapid pathogen detection diagnostics market: End Use outlook key takeaways
Figure 37 Global rapid pathogen detection diagnostics market: End Use movement analysis
Figure 38 Hospitals & clinical labs market estimates, 2021-2033 (USD Million)
Figure 39 Point-of-care market estimates, 2021-2033 (USD Million)
Figure 40 Public-health labs market estimates, 2021-2033 (USD Million)
Figure 41 Food testing labs market estimates, 2021-2033 (USD Million)
Figure 42 Others market estimates, 2021-2033 (USD Million)
Figure 43 Regional marketplace: Key takeaways
Figure 44 Global rapid pathogen detection diagnostics market: Regional movement analysis
Figure 45 North America rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 46 U.S. rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 47 Canada rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 48 Mexico rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 49 Europe rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 50 UK rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 51 Germany rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 52 France rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 53 Spain rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 54 Italy rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 55 Denmark rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 56 Sweden rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 57 Norway rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 58 Asia-Pacific rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 59 Japan rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 60 China rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 61 India rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 62 South Korea rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 63 Australia rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 64 Thailand rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 65 Latin America rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 66 Brazil rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 67 Argentina rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 68 MEA rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 69 South Africa rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 70 Saudi Arabia rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 71 UAE rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 72 Kuwait rapid pathogen detection diagnostics market, 2021-2033 (USD Million)
Figure 73 Strategy framework

Companies Mentioned

The key companies profiled in this Rapid Pathogen Detection Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • BIOMÉRIEUX
  • Danaher Corporation
  • BD
  • QIAGEN
  • Siemens Healthineers AG
  • PerkinElmer
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • Charles River Laboratories
  • DiaSorin S.p.A.

Table Information

Report AttributeDetails
No. of Pages130
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 21.05 Billion
Forecasted Market Value ( USD ) by 2033 $ 30.9 Billion
Compound Annual Growth Rate4.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report by Test, Pathogen, End-use and Region with Growth Forecasts, 2025-2033 - Product Image

Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report by Test, Pathogen, End-use and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Sepsis Diagnostics Market Analysis & Forecast to 2023-2033: Market By Product; By Technology; By Method; By Pathogen; By Testing; By End-user; and By Region - Product Image

Sepsis Diagnostics Market Analysis & Forecast to 2023-2033: Market By Product; By Technology; By Method; By Pathogen; By Testing; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033 - Product Image

Acute Care Syndromic Testing Market - A Global and Regional Analysis: Focus on Disease Type, Target, Sample Type, End User and Country Analysis - Analysis and Forecast, 2023-2033

  • Report
  • 227 Pages
  • Global
From
Enteric Disease Testing Market Size, Share, Trends and Forecast by Product Type, Technique, Disease Type, End User, and Region, 2025-2033 - Product Image

Enteric Disease Testing Market Size, Share, Trends and Forecast by Product Type, Technique, Disease Type, End User, and Region, 2025-2033

  • Report
  • 124 Pages
  • Global
From
Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area (Respiratory Infections, Enteric Infections), Technology, End Use and Region with Growth Forecasts, 2025-2033 - Product Image

Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area (Respiratory Infections, Enteric Infections), Technology, End Use and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.